Insights from 2023 ASH Annual Meeting
Avatar

ASH 2023 Insights: "CENTAURUS Study Final Analysis - Efficacy & Safety of Dara Monotherapy in Pts With Intermediate- or High-Risk SMM"

By Insights from 2023 ASH Annual Meeting FEATURING Ola Landgren
By Insights from 2023 ASH Annual Meeting FEATURING Ola Landgren
0 views
December 13, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

01:29
Incyte

Targeting CSF-1R to Manage Inflammation and Fibrosis in GVHD

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Recommended

AUTOPLAY
19:08
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGU…

Feat. R. Banerjee
32:06
Scripps Health

Should Patients With High-Risk SMM Be Treated Outside a Clinical Tri…

Feat. M. Gertz
35:27
Dana-Farber Cancer Institute

Advances in Multiple Myeloma 2024: From Bench to Bedside

Feat. K. Anderson
28:20
PleXus Communications

Why We Should Not Treat SMM

Feat. B. Derman
04:15
Indy Hematology Review

Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…

Feat. M. Gertz
32:03
Indy Hematology Review

Emerging and Current Treatment of MM: What Should We Know and What S…

Feat. K. Anderson
52:39
Yale Cancer Center

Myeloma in 2023: So Many Drugs, Yet So Few Cures

Feat. A. Chari
22:15
5th SOHO Italy Annual Conference

SOHO Italy 2023: Multiple Myeloma Cured in 2030 - What Are the Next …

Feat. K. Anderson
04:55
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "iStopMM Study - Risk Factors of Smoldering …

Feat. S. Thorsteinsdottir
19:35
Dana-Farber Cancer Institute

Updates in the Management of SMM/MGUS and the Prevention of Progress…

Feat. Y. Liu
08:35
GRACE

Oncologists' Guidance on Treating Smoldering Myeloma: Panel Dis…

Feat. A. Goodman, A. Taneja, T. Phillips
13:51
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 DEBATE: Smoldering MM - Time to Watch and Wait

Feat. A. Dispenzieri
21:16
UChicago Medicine

Myeloma 2022: Challenges and Path Forward

Feat. A. Jakubowiak
10:09
SOHO 2022 Tenth Annual Meeting

SOHO 2022: Next Questions for MM in the Coming 5-10 Years

Feat. T. Martin
10:25
5th SOHO Italy Annual Conference

SOHO Italy 2023: Is It Time for a Biomarkers-Driven Approach in Smol…

Feat. I. Ghobrial
32:49
PleXus Communications

Myeloma Rounds: Asymptomatic Patient With High-Risk SMM

Feat. N. Antao, P. Hagen
07:20
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Daratumumab, Bortezomib, Lenalidomide, and …

Feat. O. Nadeem
10:36
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Immuno-PRISM Study of Bispecific Antibodies…

Feat. O. Nadeem
14:03
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 DEBATE: Smoldering MM - Personalized Time to Treat?

Feat. S. Lonial
14:52
5th SOHO Italy Annual Conference

SOHO Italy 2023: MM State-of-the-Art in the USA and Evolving Questio…

Feat. H. Lee